Treatment Guidelines

January 17, 2022

A video interview with Joshua Joseph, MD, MPH, discussing a recent scientific statement from the American Heart Association on achieving optimal cardiovascular health management in patients with type 2 diabetes.

December 25, 2021

Each month, our editorial staff compiles a month in review highlighting the most popular content from the past month. December's month in review features new guidelines, FDA news, and more.

December 15, 2021

Released on Dec. 15, the latest scientific statement from the American Heart Association provides a comprehensive overview of the available evidence on topics related to diagnosis, management, and pharmacotherapy for hypertension during pregnancy.

December 09, 2021

The ACC/AHA/SCAI 2021 guideline recommendations for coronary artery revascularization were released on December 9, which they hope will replace or retire recommendations from half a dozen previous guidelines.

October 30, 2021

October's cardiology month in review features a pair of historic guidelines, questions around the risk of arrhythmia associated with omega-3 supplements, myocarditis and Pfizer vaccines, and more.

October 19, 2021

In a Q&A, Guy Mintz, MD, provides perspective on the USPSTF draft recommendations surrounding aspirin for primary and secondary prevention, how the role of aspirin has evolved in recent decades, and how the news has caused a surge of questions in his practice.

September 23, 2021

The American Heart Association has released a scientific statement outlining the current knowledge base surrounding potential prevention and treatment strategies for the management of obesity hypertension.

September 19, 2021

Professor Kausik Ray provides perspective on the most recent cardiovascular disease prevention guidelines debuted by the European Society of Cardiology at ESC Congress 2021.

August 31, 2021

Gregory Weiss, MD, provides an overview of the updated cardiovascular disease prevention guidelines from the European Society of Cardiology, which were released at ESC Congress 2021.

August 18, 2021

The latest scientific statement from the American Heart Association seeks to outline the cardiovascular risks associated with OSA or sleep-disordered breathing in children and adolescents while also providing insight into symptoms and risk factors for developing OSA or sleep-disordered breathing.